Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-28

Clinical Trial Update: Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN [Phase 4]

View source ↗

Summary

Phase 4 trial update of intravenous iron treatment in patients with chronic heart failure and iron deficiency (IRONMAN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous iron (unspecified formulation) (intravenous iron)

Snippet

Sponsor: University of Glasgow | Conditions: Chronic Heart Failure, Iron Deficiency | Phase 4 | Status: COMPLETED